SEP 2, 2026 · JOURNAL ARTICLE
Aspirin use is not associated with metabolic dysfunction associated fatty liver disease in the UK Biobank
Scientific Reports
Observational cohort study with propensity score matching showing no primary association between aspirin and MAFLD, with exploratory subgroup findings that the authors themselves characterize as hypothesis-generating due to multiple comparisons.
Reported
Primary endpoint: aspirin and MAF…OR = 0.97, 95% CI: 0.82–1.15
Subgroup: obesity (BMI ≥ 30)OR 0.69, 95% CI 0.52–0.92
Interaction: aspirin × strokeOR for interaction = 0.07, 95% CI: 0.008–0.…